{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:46:45Z","timestamp":1794527205045,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Republic of Serbia Ministry of Education Science and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jchromb.2025.124481","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T16:35:34Z","timestamp":1737822934000},"page":"124481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Experimental and computational analysis of lipophilicity and plasma protein binding properties of potent tacrine based cholinesterase inhibitors"],"prefix":"10.1016","volume":"1253","author":[{"given":"Sandra","family":"\u0160egan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Mosi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"\u0160ukalovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Jevti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jchromb.2025.124481_bb0005","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.4155\/fmc-2018-0435","article-title":"Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies","volume":"11","author":"Ginex","year":"2019","journal-title":"FutureMed. Chem."},{"key":"10.1016\/j.jchromb.2025.124481_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131564","article-title":"Indian ayurvedic herb, Boerhaavia diffusa as BCPR inhibitor: the story behind the curtains","volume":"1249","author":"Milo\u0161evi\u0107","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jchromb.2025.124481_bb0015","first-page":"5435","article-title":"Albumin-drug interaction and its clinical implication","volume":"2013","author":"Yamasaki","year":"1830","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.jchromb.2025.124481_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.07.015","article-title":"Application of reversed-phase thin layer chromatography and QSRR modelling for prediction of protein binding of selected -blockers","volume":"176","author":"Ciuraa","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124481_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463197","article-title":"Chemometrics of anisotropic lipophilicity of anticancer androstane derivatives determined by reversed-phase ultra-high performance liquid chromatography with polar aprotic and protic modifiers","volume":"1673","author":"Kova\u010devi\u0107","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2025.124481_bb0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2017.10.022","article-title":"Structural properties governing drug-plasma protein bindingdetermined by high-performance liquid chromatography method","volume":"149","author":"Kamblea","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124481_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.122052","article-title":"Recent advances in the determination of unbound concentration and plasma protein binding of drugs: analytical methods","volume":"225","author":"Seyfinejad","year":"2021","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.jchromb.2025.124481_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-022X(00)00143-3","article-title":"Lourdes Zat\u00f3n, data plotting of warfarin binding to human serum albumin","volume":"48","author":"Villamor","year":"2001","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.jchromb.2025.124481_bb0045","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3390\/ijms24032168","article-title":"Enantioselective human serum albumin binding of Apremilast: liquid chromatographic, fluorescence and molecular docking study","volume":"24","author":"Dombi","year":"2023","journal-title":"J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2025.124481_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114593","article-title":"The evaluation of drug-plasma protein binding interaction on immobilized human serum albumin stationary phase, aided by different computational approaches","volume":"211","author":"Obradovi\u0107","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124481_bb0055","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jps.10494","article-title":"Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol\/water and immobilized artificial membrane lipophilicity","volume":"92","author":"Valko","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2025.124481_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115916","article-title":"Modification of gradient HPLC method for determination of small molecules\u2019 affinity to human serum albumin under column safety conditions: robustness and chemometrics study","volume":"239","author":"Wozi\u0144ski","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124481_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2017.10.022","article-title":"Structural properties governing drug-plasma protein binding determined by high-performance liquid chromatography method","volume":"149","author":"Kamblea","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124481_bb0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejps.2014.04.015","article-title":"Investigation of the retention behavior of structurally diverse drugs on alpha1 acid glycoprotein column: insight on the molecular factors involved and correlation with protein binding data","volume":"60","author":"Chrysanthakopoulos","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2025.124481_bb0075","first-page":"275","article-title":"Chapter 16 - Pharmacology of Alzheimer\u2019s disease. in Neuropsychopharmacology","author":"Moini","year":"2023","journal-title":"Academic Press"},{"key":"10.1016\/j.jchromb.2025.124481_bb0080","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1039\/C5TX00096C","article-title":"The acute hepatotoxicity of tacrine explained by 1H NMR based metabolomic profiling","volume":"4","author":"Lou","year":"2015","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.jchromb.2025.124481_bb0085","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.4155\/fmc-2016-0103","article-title":"Recent progress in repositioning Alzheimer\u2019s disease drugs based on a multitarget strategy","volume":"8","author":"Santos","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jchromb.2025.124481_bb0090","article-title":"Multi-target potential of newly designed tacrine-derived cholinesterase inhibitors: synthesis, computational and pharmacological study bioorg","volume":"101","author":"Jevti\u0107","year":"2024","journal-title":"Med. Chem."},{"issue":"2","key":"10.1016\/j.jchromb.2025.124481_bb0095","first-page":"122","article-title":"The retention behavior of some sulfonamides on different TLC plates. 2. Comparison of the selectivity of the systems and quantitative determination of hydrophobicity parameters","volume":"8","author":"Bieganowska","year":"1995","journal-title":"J. Planar Chromatogr.\u2013Mod. TLC"},{"key":"10.1016\/j.jchromb.2025.124481_bb0130","series-title":"Schr\u00f6dinger Release 2024\u20134: QikProp","year":"2024"},{"key":"10.1016\/j.jchromb.2025.124481_bb0135","series-title":"Schr\u00f6dinger","year":"2024"},{"key":"10.1016\/j.jchromb.2025.124481_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jchromb.2025.124481_bb0150","series-title":"PerkinElmer Informatics","year":"2017"},{"key":"10.1016\/j.jchromb.2025.124481_bb0155","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jchromb.2025.124481_bb0160","unstructured":"MATLAB (Version 7.12.0, Budapest, Hungary)."},{"key":"10.1016\/j.jchromb.2025.124481_bb0165","series-title":"Substituent Constant for Correlation Analysis in Chemistry and Biology","author":"Hansch","year":"1979"},{"key":"10.1016\/j.jchromb.2025.124481_bb0170","doi-asserted-by":"crossref","unstructured":"Hassan Pajouhesh and George R. Lenz, Medicinal Chemical Properties of Successful Central Nervous System Drugs, NeuroRx, 2 920050. doi:https:\/\/doi.org\/10.1602\/neurorx.2.4.541 541\u2013553.","DOI":"10.1602\/neurorx.2.4.541"},{"key":"10.1016\/j.jchromb.2025.124481_bb0175","series-title":"The Pharmacological Basis of Therapeutics","first-page":"1712","author":"Goodman","year":"1996"},{"key":"10.1016\/j.jchromb.2025.124481_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2016.02.012","article-title":"Human serum albumin reduces the potency of acetylcholinesterase inhibitor based drugs for Alzheimer\u2019s disease","volume":"249","author":"Islam","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.jchromb.2025.124481_bb0185","article-title":"Spectroscopic evaluation of novel TacrineCoumarin hybrids as HSA-interacting agents","volume":"8","author":"Konko\u013eov\u00e1","year":"2019","journal-title":"Organic Med. Chem IJ."},{"issue":"19","key":"10.1016\/j.jchromb.2025.124481_bb0190","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.3390\/ijms221910593","article-title":"Esterase activity of serum albumin studied by 1H NMR spectroscopy and molecular modelling","volume":"22","author":"Belinskaia","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:47:45Z","timestamp":1740620865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023225000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"alternative-id":["S1570023225000339"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124481","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental and computational analysis of lipophilicity and plasma protein binding properties of potent tacrine based cholinesterase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124481"}}